180 results on '"Gonzales, Andrea"'
Search Results
2. Combining R and Earth Engine
3. Management Model Based on Lean Warehousing & Lean Logistic to Increase the Level of Service in SMEs in a Hardware Store
4. Laboratory safety evaluation of lokivetmab, a canine anti-interleukin-31 monoclonal antibody, in dogs
5. Lack of Interference of Oclacitinib with the results of intradermal testing or allergen-specific IgE serology in Dermatophagoides farinae-sensitized beagle dogs
6. Oclacitinib (APOQUEL®) is a selective Janus kinase 1 inhibitor with efficacy in a canine model of flea allergic dermatitis.
7. Possible Spreading of SARS-CoV-2 from Humans to Captive Non-Human Primates in the Peruvian Amazon
8. Efficient Campus Shuttle Tracking and Management Mobile Application for College Campus
9. Comparison of intradermal and serum testing for environmental allergen‐specific immunoglobulin E determination in a laboratory colony of cats with naturally acquired atopic syndrome.
10. Significant Mitigation of Blast Overpressure Exposure During Training by Adjustment of Body Position as Demonstrated With Field Data
11. Significant Mitigation of Blast Overpressure Exposure During Training by Adjustment of Body Position as Demonstrated With Field Data
12. Dynamic monitoring of service members to quantify blast exposure levels during combat training using BlackBox Biometrics Blast Gauges: explosive breaching, shoulder-fired weapons, artillery, mortars, and 0.50 caliber guns
13. Cytokine transcriptome profiling in acute experimental canine atopic dermatitis skin lesions after IL ‐31 inhibition with lokivetmab
14. Data from Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor
15. Supplementary Fig. S4 from Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor
16. Supplementary Table 1 from PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib
17. Oclacitinib 10 years later: lessons learned and directions for the future
18. Cost and performance analysis of efficiency, efficacy, and effectiveness of viral RNA isolation with commercial kits and Heat Shock as an alternative method to detect SARS-CoV-2 by RT-PCR
19. Comparative functional characterization of canine IgG subclasses
20. Allergen-induced production of IL-31 by canine Th2 cells and identification of immune, skin, and neuronal target cells
21. IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics
22. Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL ‐31‐induced pruritus
23. Um ano de pandemia: experiência do Serviço de Nutrição e Dietética de um hospital de referência para atendimento de covid-19
24. Innovation of Biodegradable Seedling Cup Made of Calamansi Peel: An Alternative Solution to Decrease Microplastic
25. In Pursuit of an Allosteric Human Tropomyosin Kinase A (hTrkA) Inhibitor for Chronic Pain
26. Development of a Fast-Running Algorithm to Approximate Incident Blast Parameters Using Body-Mounted Sensor Measurements
27. Cytokine expression in feline allergic dermatitis and feline asthma
28. Características clínico-demográficas de pacientes con ceguera irreversible en el Servicio de Oftalmología General de la Clínica Belén, Coronel Oviedo, Paraguay desde febrero del 2018 a febrero del 2019
29. The use of a HEMOCHRON® JR. HEMONOX™ point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures
30. Onset and duration of action of lokivetmab in a canine model of IL‐31 induced pruritus
31. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis
32. Lead identification and characterization of hTrkA type 2 inhibitors
33. Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA)
34. Patient needs and priorities for patient navigator programmes in chronic kidney disease: a workshop report
35. Serum concentrations of IL‐31 in dogs with nonpruritic mast cell tumours or lymphoma
36. COVID-19
37. G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein
38. Evaluación docente por los estudiantes del VII ciclo de secundaria de la Institución Educativa Leoncio Prado de Trita
39. Development of a Fast-Running Algorithm to Approximate Incident Blast Parameters Using Body-Mounted Sensor Measurements
40. COVID-19: Contingency actions for the provision of meals to employees of a university hospital in southern Brazil
41. Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-88204E
42. Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family
43. Synthetic inhibitor leads of human tropomyosin receptor kinase A (hTrkA)
44. HELMINTOS DEL GÉNERO DIDELPHIS (DIDELPHIMORPHIA: DIDELPHIDAE) DE CUATRO REGIONES DEL PERÚ
45. Update on pathogenesis, diagnosis, and treatment of atopic dermatitis in dogs
46. Avaliação de análise microbiológica de sobremesas servidas a pacientes internados em hospital da cidade de Porto Alegre/RS
47. Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family
48. Response
49. Synthetic inhibitor leads of human tropomyosin receptor kinase A (hTrkA)Atomic coordinates of the kinase domain of hTrkA. Ligand have been deposited in Protein Data Bank (PDB) under PDB codes 1: 6PMB; 3: 6PMA; 5: 6PME; 6: 6PMC.The manuscript was written by G. S. All authors have given approval to the final version of the manuscript.All experimental procedures are available as part of the ESI in ref. 23–25.Electronic supplementary information (ESI) available: Computational workflow and X-ray data collection and structure determination details. See DOI: 10.1039/c9md00554d
50. IL‐31‐induced pruritus in dogs: a novel experimental model to evaluate anti‐pruritic effects of canine therapeutics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.